- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07469215
Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors
A Pilot Randomized Controlled Trial of Behavioral Parent Training (BPT) With or Without AI Support in Children With Disruptive Behaviors
The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children who have disruptive behavior problems. It will also help researchers understand if the app is easy to use and helpful for parents.
The main question it aims to answer is:
- Is it feasible and acceptable for parents to use the AI app alongside their therapy sessions?
The secondary questions it aims to answer are:
- Does the app help reduce children's disruptive behaviors and irritability more than therapy alone?
- Does using the app help lower stress, anxiety, and depression levels for the parents?
Researchers will compare:
- Standard BPT: Parents receive 8 weekly group training sessions (online).
- BPT plus ParenteAI: Parents receive the same 8 weekly sessions plus 24/7 access to an AI virtual assistant for personalized support.
Participants will:
- Attend 8 weekly group training sessions.
- Complete surveys about their child's behavior and their own well-being at baseline, after group training sessions 4 and 8, and 3 and 6 months after finalizing the group training.
- If in the experimental group, use the ParenteAI app to get real-time coaching and support for managing their child's behavior at home.
- Provide feedback on their experience and satisfaction with the program.
Study Overview
Status
Conditions
Detailed Description
This study seeks to evaluate new ways to support families with children exhibiting disruptive behavior problems, one of the leading causes of referral to mental health services. Although Behavioral Parent Training (BPT) has proven to be a highly effective treatment, many children do not receive adequate care due to a lack of resources and overstretched services. Therefore, this project explores whether the use of the AI-based application can increase the efficacy and accessibility of BPT.
Objectives: The primary objective is to examine the feasibility of adding the AI app to group-based BPT (acceptability, utility, satisfaction, therapeutic alliance, and attendance).
As a secondary objective, the study will evaluate the clinical impact of the AI app in reducing disruptive behaviors and irritability in children, as well as decreasing symptoms of depression, anxiety, and stress in parents.
Design: This is a randomized controlled trial with two conditions: (A) a control group, which will receive 8 weekly sessions of BPT (online) followed by treatment as usual for 6 months; and (B) an experimental group, which will receive the same BPT plus continuous access to the ParenteAI app, offering automated and personalized support via a 24/7 virtual assistant. Group assignment will be randomized using balanced blocks.
Outcome Measures:
Primary: Acceptability, utility (TAI), satisfaction (NPS), therapeutic alliance (WAI-SR), attendance, and dropout rates.
Secondary: Disruptive behaviors (ECBI), irritability (ARI), parental symptoms of depression, anxiety, and stress (DASS-21), and general psychopathology (SDQ), in addition to sociodemographic data and clinical diagnoses. Qualitative assessments of the experience with ParenteAI will also be collected.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pablo Vidal-Ribas Belil, PhD
- Phone Number: +34644890465
- Email: pablo.vidalribas@sjd.es
Study Contact Backup
- Name: Eduardo L Bunge, PhD
- Email: pauvrb@gmail.com
Study Locations
-
-
Barcelona
-
Barcelona, Barcelona, Spain, 08950
- Recruiting
- Hospital Sant Joan de Déu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a primary caregiver with a child aged 5 to 12 years exhibiting disruptive behaviors (e.g., symptoms of ODD, CD, IED, ADHD, and/or unspecified behavioral problems).
- Having access to an electronic device and regular internet access.
- Stable concomitant intervention including medications throughout the study.
- Speak Spanish or Catalan language.
- Signed informed consent by parents or legal guardians of the child.
Exclusion Criteria:
- Having ASD as primary diagnosis.
- Psychosis, self-harming behaviors, severe mood disorder.
- Known Intelligent quotient < 70
- Caregivers and/or children receiving any concurrent psychological treatment.
- No signing the informant consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: BPT
Parents that receive 8 weekly online sessions of behavioral parent training (BPT).
The program will include 8 sessions, including psychoeducation about goals and behaviors, special time, praise, clear instructions, rewards, active ignoring, cool down time, and school behavior.
The BPT sessions are basedon a combination of the Module of conduct problems of the MATCH-ADCT program from Chorpita and Weisz (Modular Approach to Therapy for Children wit h Anxiety, Depression, Trauma, or Conduct Problems) (Chorpita & Weisz, 2009), the BPT program from Russell A. Barkley (Barkley, R.A., 2013.
Defiant children: A clinician's manual for assessment and parent training.
Guilford press.), and the program from Alan E. Kazdin (Kazdin, A. E. (2005).
Parent management training: Treatment for oppositional, aggressive, and antisocial behavior in children and adolescents.
Oxford University Press.).
|
Eight (8) weekly online sessions of BPT
Other Names:
|
|
Experimental: BPT+AI app
Parents that receive 8 weekly online sessions of behavioral parent training (BPT) and have access to AI app 24/7.
Parents will be given access to ParenteAI app and will be asked to open an account.
When starting the app, they will be greeted by a therapist assistant called PAT (an AI agent) that will guide parents through different stages of BPT modules and ask any question they might have anytime anywhere in form of a chatbot.
Specifically, the app has two dashboards: 1) A behavioral parent training divided in 8 core modules and several optional modules, in which PAT provides evidence-based manualized BPT, and that mirror the sessions from the BPT group.
Parents using ParenteAI will work on each module the week before that topic is discussed in the BPT groups.
2) A chatbot with a curated knowledge base on BPT (trained on same manuales) where parents can talk and ask questions to PAT about anything related to parenting, providing specific feedback, 24/7.
|
Eight (8) weekly online sessions of BPT supported by AI app, with access 24/7 from baseline to 6 month follow up after last group session.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of AI support
Time Frame: From enrollment to the end of treatment at 6 months follow up
|
This will be measured by the total number of modules completed, number of In-the-moment support interactions with ParenteAi initiated by parent, number of messages exchanged, words sent by the parent, and average words per message.
|
From enrollment to the end of treatment at 6 months follow up
|
|
Usefulness of BPT with or without AI support
Time Frame: Week 4 and 8 (Postreatment)
|
This will be measured with the Therapy Attitude Inventory (TAI; Eyberg, 1993 Eyberg & Johnson, 1974).
The TAI measures satisfaction with parent training, parent-child treatments, and family therapy.
The scale consists of 10 items rated on a five-point Likert scale, with 1 indicating dissatisfaction or worsening of problems and 5 indicating maximum satisfaction or improvement.
The total score ranges from 10 to 50.
|
Week 4 and 8 (Postreatment)
|
|
Satisfaction with AI application support
Time Frame: Week 8 (Post-treatment)
|
This will be measured with the Net Promoter Score (NPS), a metric that measures the likelihood of parents, in this case, recommending the use of Parente.AI application to other parents with similar problems.
The NPS is calculated by asking parents to rate, on a scale of 0 to 10, how likely they are to recommend.
The score is then derived by subtracting the percentage of "detractors" (those who score 0-6) from the percentage of "promoters" (those who score 9-10).
The resulting score ranges from -100 to +100.
|
Week 8 (Post-treatment)
|
|
Therapeutic alliance with AI-assistant
Time Frame: Week 4, Week 8 (Post-treatment), 3-month follow-up, and 6-month follow-up.
|
Therapeutic alliance with PAT (AI-assisted therapist) will be measured with the Working Alliance Inventory (WAI-SR).
The WAI measures three important aspects of the therapeutic alliance: 1. Agreement about the therapeutic tasks, 2. Agreement about the therapeutic goals, and 3.
The affective bond between clinician and client.
The Working Alliance Inventory-Short Revised (WAI-SR) is a refined version designed to measure these key aspects with greater clarity and efficiency.
|
Week 4, Week 8 (Post-treatment), 3-month follow-up, and 6-month follow-up.
|
|
Treatment Attendance Rate
Time Frame: Through the end of the 8-week intervention
|
Percentage of group sessions attended.
Calculated as (Sessions Attended / Total Sessions) x 100.
|
Through the end of the 8-week intervention
|
|
Study Dropout Rate
Time Frame: Week 8 (Post-treatment), 3-month follow-up, and 6-month follow-up.
|
Percentage of participants who withdraw from the study or discontinue the intervention.
|
Week 8 (Post-treatment), 3-month follow-up, and 6-month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Disruptive Behavior (ECBI)
Time Frame: Baseline, Week 4, Week 8, 3-month follow-up, and 6-month follow-up
|
The ECBI is a 36-item parent-report questionnaire used to assess the frequency and severity of disruptive behaviors in children aged 2-16.
Parents rate each item on two scales; the intensity scale measures how frequently the behavior occurs on a 7-point Likert scale (1=never, 7=always), and the problem scales indicates whether the parent considers the behavior a problem (yes/no).
|
Baseline, Week 4, Week 8, 3-month follow-up, and 6-month follow-up
|
|
Child Irritability (ARI)
Time Frame: Baseline, Week 4, Week 8, 3-month follow-up, and 6-month follow-up
|
Measured via the Affective Reactivity Index.
Total score ranges from 0 to 12; higher scores indicate greater irritability
|
Baseline, Week 4, Week 8, 3-month follow-up, and 6-month follow-up
|
|
Parental Psychological Distress (DASS-21)
Time Frame: Baseline, Week 8 (Post-treatment), and 6-month follow-up
|
Measured via the Depression, Anxiety, and Stress Scale.
Evaluates negative emotional states across three subscales.
Higher scores indicate greater distress.
|
Baseline, Week 8 (Post-treatment), and 6-month follow-up
|
|
General Psychopathology and Impact (SDQ)
Time Frame: Baseline, Week 8 (Post-treatment), and 6-month follow-up
|
Measured via the Strengths and Difficulties Questionnaire.
Total difficulties score ranges from 0 to 40; higher scores indicate greater emotional/behavioral problems.
Includes an Impact supplement with scores ranging 0-10, higher scores indicate greater impairment.
|
Baseline, Week 8 (Post-treatment), and 6-month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative Feedback on AI application
Time Frame: Week 8 (Post-treatment)
|
Open-ended assessment of parental experience using two questions: "What did you like the most?" and "What would you recommend improving?"
|
Week 8 (Post-treatment)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pablo Vidal-Ribas Belil, PhD, Fundació de Recerca Sant Joan de Déu
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIC-172-25
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritability
-
National Institute of Mental Health (NIMH)Recruiting
-
National Institute of Mental Health (NIMH)RecruitingIrritabilityUnited States
-
Hospital de Clinicas de Porto AlegreCompleted
-
Kley Hertz S/ACompleted
-
Kley Hertz S/AUnknown
-
Kley Hertz S/ACompleted
-
Kley Hertz S/AUnknown
-
University of North Carolina, Chapel HillFoundation of Hope for the Research and Treatment of Mental IllnessNot yet recruitingIrritability | Depression - Major Depressive DisorderUnited States
-
University of OxfordWellcome Trust; Oxford Health Biomedical Research Centre (OH BRC) support schemeRecruitingDepression | Irritability | Depression - Major Depressive DisorderUnited Kingdom
-
Karuna Therapeutics, Inc., a Bristol Myers Squibb...Karuna Therapeutics, Inc., a Bristol Myers Squibb companyRecruitingSchizophrenia | Autism-Related IrritabilityUnited States, Japan, Argentina, Romania, Canada, France, Germany, Hungary, Poland, Spain
Clinical Trials on Behavioral Parent Training (BPT)
-
NYU Langone HealthCompleted
-
University of CreteCompletedAttention Deficit Disorder With Hyperactivity | Attention DeficitGreece
-
Florida State UniversityRecruiting
-
Wuhan Mental Health CentreCompletedAttention Deficit Hyperactivity Disorder (ADHD)China
-
Kent State UniversityNational Institute of Nursing Research (NINR)CompletedCustodial GrandparentsUnited States
-
Assuta Hospital SystemsTel Aviv UniversityCompleted
-
University of Maryland, College ParkNational Institute of Mental Health (NIMH)CompletedDepression | Attention Deficit Disorder With HyperactivityUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedDisruptive Behavior DisordersUnited States
-
University of KentuckyCompletedAttention Deficit and Disruptive Behavior Disorders | Parenting | Hearing LossUnited States